PBS Calendars

Page last updated: 28 November 2024

PBS related activities surrounding the PBAC meeting cycles

Sponsors who are concerned they cannot meet the deadline to list a new brand that will trigger a first new brand price reduction, are encouraged to email PBSPricing@health.gov.au to discuss available options.

If you are considering applying to have a drug listed on the PBS, it is recommended that you contact the Office of Health Technology Assessment (OHTA) to discuss the listing steps. If you are unsure of the most appropriate person to contact, the Industry Liaison Officer will be able to assist.

All contact details are available from the PBS contacts page.

PBAC Cycle Timeframe for 2024 - 2026

PBAC Cycle Timeframe for 2024 - 2026 (PDF 436KB) - (Word 64KB)

MEETING

2024/2
10-12 July

2024/3
6-8 November

2025/1
12-14 March

2025/1.5
9-10 May

2025/2
9-11 July

2025/3
5-7 November

2026/1
11-13 March

Activity

Wk

Date

Wk

Date

Wk

Date

 

 

Wk

Date

Wk

Date

Wk

Date

Deadline for Notice of Intent for integrated co-dependent submissions (Wednesday 5pm AEST)

-8

17 Jan 2024

-8

15 May 2024

-8

11 Sep 2024

-8

N/A

-8

15 Jan 2025

-8

14 May 2025

-8

10 Sep 2025

 

-7

 

-7

 

-7

 

-7

 

-7

 

-7

 

-7

 

 

-6

 

-6

 

-6

 

-6

 

-6

 

-6

 

-6

 

 

-5

 

-5

 

-5

 

-5

 

-5

 

-5

 

-5

 

Deadline for Notice of Intent for Category 1-4 and Committee Secretariat submissions and Standard Re-entry resubmissions (Wednesday 5pm AEST)
 

-4

14 Feb 2024

-4

12 Jun 2024

-4

9 Oct 2024

-4

N/A

-4

12 Feb 2025

-4

11 June 2025

-4

8 Oct 2025

Deadline for integrated co-dependent submissions (Wednesday 5pm AEST)

-4

14 Feb 2024

-4

12 Jun 2024

-4

9 Oct 2024

-4

N/A

-4

12 Feb 2025

-4

11 June 2025

-4

8 Oct 2025

 

-3

 

-3

 

-3

 

-3

 

-3

 

-3

 

-3

 

 

-2

 

-2

 

-2

 

-2

 

-2

 

-2

 

-2

 

 

-1

 

-1

 

-1

 

-1

 

-1

 

-1

 

-1

 

Deadline for Category 1 to 4 and Committee Secretariat submissions; and Facilitated Resolution Pathway and Standard Re-entry Pathway resubmissions (Wednesday 5pm AEST)

 

0

13 Mar 2024

0

10 Jul 2024

0

6 Nov 2024

0

N/A

0

12 Mar 2025

0

9 July 2025

0

5 Nov 2025

 

1

 

1

 

1

 

1

 

1

 

1

 

1

 

 

2

 

2

 

2

 

2

 

2

 

2

 

2

 

Publication of the main Agenda on web (Wednesday)

3

3 Apr 2024

3

31 Jul 2024

3

27 Nov 2024

3

18 December 2024

3

2 Apr 2025

3

30 Jul 2025

3

26 Nov 2025

Consumer Comments open

(Wednesday)

3

3 Apr 2024

3

31 Jul 2024

3

27 Nov 2024

3

30 January 2025 (Thursday)

3

2 Apr 2025

3

30 Jul 2025

3

26 Nov 2025

 

4

 

4

 

4

 

4

 

4

 

4

 

4

 

Deadline for pre-submission meeting requests to meet 8 week cut-off

5

19 April 2024

5

16 August 2024

5

13 December 2024

5

N/A

5

17 April 2025 (18 PH)

5

15Aug 2025

5

12 Dec 2025

Deadline for Notice of Intent for Re-entry Pathway resubmissions (Friday 5pm AEST)

6

26 Apr 2024

6

23 Aug 2024

6

20 Dec 2024

6

N/A

6

24 Apr 2025

(25 PH)

6

22 Aug 2025

6

19 Dec 2025

Deadline for Early Re-entry Pathway resubmissions (Friday 5pm AEST)

7

3 May 2024

7

30 Aug 2024

7

3 Jan 2025

(Dept Shutdown 25 Dec – 1 Jan)

7

N/A

7

2 May 2025

7

29 Aug 2025

7

2 Jan 2026

(Dept Shutdown 25 Dec – 1 Jan)

Publication of the updated Agenda on web

(Friday)

8

10 May 2024

8

6 Sept 2024

8

10 Jan 2025

8

7 March 2025

8

9 May 2025

8

5 Sept 2025

8

9 Jan 2026

Pre-submission meetings: 8 week cut-off

9

13-17 May 2024

9

9-13 Sept 2024

9

13-17 Jan 2025

9

N/A

9

12-16 May 2025

9

8-12 Sept 2025

9

12-16 Jan 2026

Submission commentaries to Applicants (Wednesday)

10

22 May 2024

10

18 Sept 2024

10

22 Jan 2025

10

21 March 2025 (Friday)

10

21 May 2025

10

17 Sept 2025

10

21 Jan 2026

Consumer comments close (Wednesday); and

 

11

29 May 2024

11

25 Sep 2024

11

29 Jan 2025

11

26 March 2025

11

28 May 2025

11

24 Sep 2025

11

28 Jan 2026

Applicants’ Pre-Subcommittee Responses (PSCRs) to PBAC Secretariat (midday Wednesday)

 

11

29 May 2024

11

25 Sep 2024

11

29 Jan 2025

 

28 March 2025 (Friday)

 

28 May 2025

11

24 Sep 2025

11

28 Jan 2026

DUSC meeting (Thursday-Friday)

 

12

6-7 June 2024

12

3-4 Oct 2024

12

6-7 Feb 2025

12

4 April 2025 (Friday)

12

5-6 Jun 2025

12

2-3 Oct 2025

12

5-6 Feb 2026

 

ESC meeting (Monday-Tuesday)

13

11-12 Jun 2024

(10 PH)

13

8-9 Oct 2024

(7 PH)

13

10-11 Feb 2025

13

7-8 April 2025

13

10-11 Jun 2025

(9 PH)

13

7-8 Oct 2025
(6 PH)

13

9-10 Feb 2026

Deadline for item delist submissions (Monday 5pm AEST)

14

17 Jun 2024

14

14 Oct 2024

14

17 Feb 2025

14

N/A

14

16 Jun 2025

14

13 Oct 2025

14

16 Feb 2026

Submission overviews, ESC, DUSC & ATAGI (vaccine submissions) advice & summary of consumer comments to Applicants (Wednesday)

15

26 Jun 2024

15

23 Oct 2024

15

26 Feb 2025

15

23 April 2025

15

25 Jun 2025

15

22 Oct 2025

15

26 Feb 2026

Applicants send Pre-PBAC Responses to PBAC Secretariat (by midday Wednesday)

16

3 Jul 2024

16

30 Oct 2024

16

5 Mar 2025

16

30 April 2025

16

2 Jul 2025

16

29 Oct 2025

16

4 Mar 2026

PBAC MEETING (Wednesday-Friday)

17

10-12 July 2024

17

6-8 Nov 2024

17

12-14 March 2025

17

9-10 May 2025 (Friday-Saturday)

17

9-11 July 2025

17

5-7 Nov 2025

17

11-13 March 2025

POST PBAC PROCEDURES:

18

 

18

 

18

 

18

 

18

 

18

 

18

 

 

19

 

19

 

19

 

19

 

19

 

19

 

19

 

Ratified Minutes (positive outcomes) to Applicants (Friday)

20

2 Aug 2024

20

29 Nov 2024

20

4 Apr 2025

20

30 May 2025

20

1 Aug 2025

20

28 Nov 2025

20

3 Apr 2026

Publication of the PBAC December Intracycle Agenda on web (Friday)

21

N/A

21

6 Dec 2024

21

N/A

21

N/A

21

N/A

21

5 Dec 2025

21

N/A

PBAC DECEMBER INTRACYCLE MEETING (Friday)

22

N/A

22

13 Dec 2024

22

N/A

22

N/A

22

N/A

22

12 Dec 2025

22

N/A

Ratified Minutes (all other outcomes) to Applicants (Friday)

22

16 Aug 2024

22

13 Dec 2024

22

17 Apr 2025

(18 PH)

22

13 June 2025

22

15 Aug 2025

22

12 Dec 2025

22

16 Apr 2026

Post-PBAC meetings with PBAC Chair (Tue-Wed)

23

20-21 Aug 2024

23

17-18 Dec 2024

23

22-23 Apr 2025
(25 PH)

23

17-18 June 2025

23

19-20 Aug 2025

23

16-17 Dec 2025

23

21-22 Apr 2026

Posting of outcomes on website following Applicants’ comments (Friday); and deadline for Notice of Intent for Early Resolution Pathway resubmissions (Friday 5pm AEST)

23

23 Aug 2024

23

20 Dec 2024 (25 Dec – 1 Jan Dept shutdown)

23

24 Apr 2025 (25 PH)

23

20 June 2025

23

22 Aug 2025

23

19 Dec 2025 (25 Dec – 1 Jan Dept shutdown)

23

24 Apr 2026

Deadline for Independent Review requests for reconsideration at the meeting following the next meeting (Friday); and

deadline for Early Resolution Pathway resubmissions (Friday 5pm AEST)

24

30 Aug 2024

 

 

 

24

3 Jan 2025

 

 

24

2 May 2025

 

 

24

27 June 2025

24

29 Aug 2025

 

 

24

2 Jan 2026

 

 

24

1 May 2026

Publication of the PBAC Intracycle Agenda on web (Friday) (except December meeting)

24

30 Aug 2024

24

N/A

24

18 December 2024

24

N/A

24

29 Aug 2025

24

N/A

24

1 May 2026

PBAC INTRACYCLE MEETING (Friday) (except December meeting); and

25

6 Sept 2024

25

N/A

25

9-10 May 2025

(Friday-Saturday)

25

N/A

25

5 Sept 2025

25

N/A

25

8 May 2026

PBAC December Intracycle ratified minutes (positive outcomes) to Applicants (Friday)

25

N/A

25

10 Jan 2025

25

N/A

25

N/A

25

N/A

25

9 Jan 2026

25

N/A

 

26

 

26

 

26

 

26

 

26

 

26

 

26

 

Draft Public Summary Documents (PSDs) to Applicants (Friday); and

 

PBAC December Intracycle ratified minutes (all other outcomes) to Applicants (Friday)

27

20 Sept 2024

27

24 Jan 2025

27

23 May 2025

27

18 Jul 2025

27

19 Sep 2025

27

23 Jan 2026

27

22 May 2026

 

PBAC December Intracycle Post-PBAC meetings with PBAC Chair (Tue-Wed)

28

N/A

28

28-29 Jan 2025

28

N/A

28

N/A

28

N/A

28

27-28 Jan 2026

28

N/A

PBAC Intracycle ratified minutes (positive outcomes) to Applicants (Friday) (except December meeting)

28

27 Sept 2024

28

N/A

28

30 May 2025

28

30 May 2025

28

26 Sep 2025

28

N/A

28

29 May 2026

PBAC December Intracycle posting of outcomes on website

28

N/A

28

31 Jan 2025

28

N/A

28

N/A

28

N/A

28

30 Jan 2026

28

N/A

 

29

 

29

 

29

 

29

 

29

 

29

 

29

 

PBAC Intracycle ratified minutes (all other outcomes) to Applicants (Friday)

30

11 Oct 2024

30

14 Feb 2025

30

13 Jun 2025

30

13 Jun 2025

30

10 Oct 2025

30

13 Feb 2026

30

12 June 2026

PBAC Intracycle Post-PBAC meetings with PBAC Chair (Tue-Wed) (except December meeting)

31

15-16 Oct 2024

 

31

N/A

 

31

17-18 Jun 2025

 

31

17-18 Jun 2025

31

14-15 Oct 2025

 

31

N/A

31

16-17 June 2026

Final PSDs to Applicants (Friday)

31

18 Oct 2024

31

21 Feb 2025

31

20 Jun 2025

31

15 Aug 2025

31

17 Oct 2025

31

20 Feb 2026

31

19 June 2026

PBAC Intracycle posting of outcomes on website (except December meeting)

31

18 Oct 2024

31

N/A

31

20 Jun 2025

31

20 Jun 2025

31

17 Oct 2025

31

N/A

31

19 June 2026

Draft PBAC December Intracycle PSDs to Applicants (Friday)

32

N/A

32

28 Feb 2025

32

N/A

32

N/A

32

N/A

32

27 Feb 2026

32

N/A

PSDs published on website (positive & subsequent rejections) (Friday)

33

1 Nov 2024

33

7 Mar 2025

33

4 Jul 2025

33

N/A

33

31 Oct 2025

33

6 Mar 2026

33

3 July 2026

 

34

 

34

 

34

 

34

 

34

 

34

 

34

 

PSDs published on website (1st time not recommends & deferrals) (Friday);and

35

15 Nov 2024

35

21 Mar 2025

35

18 Jul 2025

35

N/A

35

14 Nov 2025

35

20 Mar 2026

35

17 July 2026

Draft PBAC Intracycle PSDs to Applicants (Friday) (except December meeting)

35

15 Nov 2024

35

N/A

35

18 Jul 2025

35

18 Jul 2025

35

14 Nov 2025

35

N/A

35

17 July 2026

Final PBAC December Intracycle PSDs to Applicants (Friday)

36

N/A

36

28 Mar 2025

36

N/A

36

N/A

36

N/A

36

27 March 2026

36

N/A

 

37

 

37

 

37

 

37

 

37

 

37

 

37

 

PBAC December Intracycle PSDs published on website (positive & subsequent not recommends) (Friday)

38

N/A

38

11 Apr 2025

38

N/A

38

N/A

38

N/A

38

10 Apr 2026

38

N/A

Final PBAC Intracycle PSDs to Applicants (Friday) (except December meeting)

39

13 Dec 2024

39

N/A

39

15 Aug 2025

39

15 Aug 2025

39

12 Dec 2025

39

N/A

39

14 Aug 2026

PBAC December Intracycle PSDs published on website (1st time not recommends & deferrals) (Friday)

40

N/A

40

24 Apr 2025

(25 PH)

40

N/A

40

N/A

40

N/A

40

24 Apr 2026

40

N/A

PBAC Intracycle PSDs published on website (positive & subsequent not recommends) (Friday) (except December meeting)

41

24 Dec 2024

(24 Dec –1 Jan Dept shutdown)

41

N/A

41

29 Aug 2025

41

29 Aug 2025

41

24 Dec 2025

(24 Dec – 5 Jan Dept shutdown)

41

N/A

41

28 Aug 2026

 

42

 

42

 

42

 

42

 

42

 

42

 

42

 

PBAC Intracycle PSDs published on website (1st time not recommends & deferrals) (Friday) (except December meeting)

43

17 Jan 2025

43

N/A

43

12 Sept 2025

43

12 Sept 2025

43

16 Jan 2026

43

N/A

43

11 Sept 2026

PBAC = Pharmaceutical Benefits Advisory Committee

“responsible persons” = legal wording requirement for terminology – previously known as sponsors
DUSC = Drug Utilisation Sub Committee    
ESC = Economic Sub Committee
ATAGI = Australian Technical Advisory Group on Immunisation
PSDs = Public Summary Documents
TBC = To be Confirmed
    
*  These dates may vary based on the number of submissions received    

Accessibility

The documents on this page may not be accessible. If you need help please please contact the HTA Support Unit (htasupportunit@health.gov.au)

Pre-submission meetings

Sponsors may apply for a pre-submission meeting with the Department at any time. Pre-submission meetings are held throughout the entire PBAC meeting cycle, subject to availability. Please refer to the PBS Calendar above in relation to cut-off dates for applications submitting to the next major submission deadline. Additional information on procedures and links to application and briefing paper templates are outlined in the Procedure guidance for listing medicines on the Pharmaceutical Benefits Scheme.

If the item to be discussed is a co-dependent technology, sponsors should separately contact the Health Technology Assessment (HTA) team (hta@health.gov.au) to discuss the required MSAC processes.

Health technologies are co-dependent if their use needs to be combined (either sequentially or simultaneously) to achieve or enhance the intended clinical effect of either technology.  For example, a drug/test combination where a new medicine seeking listing on the PBS may have a related pathology test that helps to determine the population group for that medicine.

If you have any questions regarding pre-submission meetings, please contact the Pre-submission Meetings Team via email (PBACpresubmissionmeetings@health.gov.au).